Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure

Leukemia and Lymphoma

Volumn 54, Issue 8, 2013, Pages 1724-1729

  Mokart, Djamel ^a   Lambert, Jérôme ^b   Schnell, David ^b   Fouché, Louis ^a   Rabbat, Antoine ^c   Kouatchet, Achille ^d   Lemiale, Virginie ^e   Vincent, François ^f   Lengliné, Etienne ^b   Bruneel, Fabrice ^g   Pene, Frederic ^e   Chevret, Sylvie ^b   Azoulay, Elie ^b  

^a INSTITUT PAOLI CALMETTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔTEL DIEU   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e CHU Cochin ^*  (France)

^f AVICENNE HOSPITAL   (France)

^g Service de Réanimation Médico Chirurgicale   (France)

Author keywords

Acute respiratory failure; Hematology; ICU; Oncology; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; HYPERTENSIVE FACTOR; PREDNISONE; PROTEIN TYROSINE KINASE INHIBITOR; RITUXIMAB; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE RESPIRATORY FAILURE; ADD ON THERAPY; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FIBEROPTIC BRONCHOSCOPY; HOSPITAL ADMISSION; HUMAN; HYPOXEMIA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; NONHODGKIN LYMPHOMA; OXYGEN THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; THERAPY DELAY;

AGED; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT ADMISSION; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY INSUFFICIENCY;

EID: 84880260686     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.753446     Document Type: Article

References (34)

1. Azoulay E, Schlemmer B. Diagnostic strategy in cancer patients withacute respiratory failure. Intensive Care Med 2006; 32: 808-822
2. Azoulay E, Thiery G, Chevret S, et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 2004 ; 83 : 360-370
3. Lecuyer L, Chevret S, Guidet B, et al. Case volume and mortality in haematological patients withacute respiratory failure. Eur Respir J 2008 ; 32 : 748-754
4. Benoit D D, Vandewoude K H, Decruyenaere J M, et a l. Outcome and early prognostic indicators in patients witha hematologic malignancy admitted to the intensive care unit for a life-Threatening complication. Crit Care Med 2003 ; 31 : 104-112
5. Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996 ; 32A : 1135-1141
6. Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infi ltrates, fever, and acute respiratory failure. NEngl J Med 2001; 344: 481-487
7. Soares M, Salluh JI, Carvalho MS, et al. Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 2006 ; 24 : 4003-4010
8. Zuber B, Tran TC, Aegerter P, et al. Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 2012 ; 40 : 55-62
9. Thiery G, Azoulay E, Darmon M, et al. Outcome of cancer patients considered for intensive care unit admission: A hospital-wide prospective study. J Clin Oncol 2005 ; 23 : 4406-4413
10. Azoulay E, Mokart D, Lambert J, et al. Diagnostic strategy for hematology and oncology patients withacute respiratory failure: Randomized controlled trial. Am J Respir Crit Care Med 2010 ; 182 : 1038-1046
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Defi nitions for sepsis and organ failure. and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992 ; 20 : 864-874
12. Le Gall J R, Klar J, Lemeshow S, et a l. The logistic organ dysfunction system. Anew way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 1996; 276: 802-810
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992 ; 45 : 613-619
14. Azoulay E, Mokart D, Rabbat A, et a l. Diagnostic bronchoscopy in hematology and oncology patients withacute respiratory failure: Prospective multicenter data. Crit Care Med 2008 ; 36 : 100-107
15. Lecuyer L, Chevret S, Thiery G, et al. The ICU trial: A new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007 ; 35 : 808-814
16. Brenner H, Gondos A, Arndt V. Recent major progress in longterm cancer patient survival disclosed by modeled period analysis. J Clin Oncol 2007 ; 25 : 3274-3280
17. Barlogie B, Alexanian R, Dicke KA, et al. High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 1987 ; 70 : 869-872
18. Talpaz M, Shah NP, Kantarjian H, et al. Dasatinib in imatinibresistant Philadelphia chromosome-positive leukemias. NEngl J Med 2006 ; 354 : 2531-2541
19. Lecuyer L, Chevret S, Thiery G, et al. The ICU trial: A new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007 ; 35 : 808-814
20. Pene F, Aubron C, Azoulay E, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: A reappraisal of indications for organ failure supports. J Clin Oncol 2006 ; 24 : 643-649
21. Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. NEngl J Med 2010 ; 363 : 2091-2101
22. Legrand M, Max A, Peigne V, et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 2012; 40: 43-49
23. Le Gall JR, Lemeshow S, Saulnier F. Anew Simplifi ed Acute Physiology Score (SAPS II) based on a European/Northamerican multicenter study. JAMA 1993 ; 270 : 2957-2963
24. Schellongowski P, Staudinger T, Kundi M, et al. Prognostic factors for intensive care unit admission, intensive care outcome, and postintensive care survival in patients with de novo acute myeloid leukemia: A single center experience. Haematologica 2011 ; 96 : 231-237
25. Buchner T, Berdel WE, Wormann B, et al. Treatment of older patients withaML. Crit Rev Oncol Hematol 2005; 56: 247-259
26. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. NEngl J Med 2002; 346: 235-242
27. Thieblemont C, Coiffier B. Lymphoma in older patients. J Clin Oncol 2007 ; 25 : 1916-1923
28. Ribera JM. Optimal approach to treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: How to best use all the available tools. Leuk Lymphoma 2012 Aug 13. [Epub ahead of print]
29. Mrozek K, Marcucci G, Nicolet D, et al. Prognostic signifi cance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults withacute myeloid leukemia. J Clin Oncol 2012 Sep 17. [Epub ahead of print]
30. Azoulay E, Soares M, Darmon M, et al. Intensive care of the cancer patient: Recent achievements and remaining challenges. Ann Intensive Care 2011; 1 : 5
31. Mokart D, Etienne A, Esterni B, et al. Critically ill cancer patients in the intensive care unit: Short-Term outcome and 1-year mortality. Acta Anaesthesiol Scand 2012 ; 56 : 178-189
32. Azoulay E, Afessa B. The intensive care support of patients with malignancy: Do everything that can be done. Intensive Care Med 2006 ; 32 : 3-5
33. Lengline E, Raff oux E, Lemiale V, et a l. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 2012; 53: 1352-1359
34. Gruson D, Vargas F, Hilbert G, et al. Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia. Intensive Care Med 2004; 30: 965-971